Who we are
The Centre for Genetic Medicine (CGM) will provide SickKids with a unique opportunity to deploy leadership in genetics and child health to make a profound and lasting contribution in areas of discovery, translation and education. The centre concept is key to the advancement of SickKids’ Strategic Directions, enabling a heightened commitment to innovation and integration.
The Executive Committee is responsible for oversight of the centre, identification and implementation of its strategic priorities and application of its financial resources to achieve those priorities.
Executive Committee (EC) Membership
- Dr. Stephen Scherer – Centre Co-Director; Director, The Centre for Applied Genomics (Chair)
- Dr. Sarah Bowdin – Interim Centre Co-Director; Staff Physician, Clinical and Metabolic Genetics
- Dr. Peter Ray – Head, Division of Molecular Genetics, Department of Paediatric Laboratory Medicine
- Cheryl Shuman – Director, Genetic Counselling
- Chris Carew – Director of Strategy, Centre for Genetic Medicine
- Monica Justice - Head, Genetics and Genome Biology
Medical Appointments to Centre Executive Committee
Executive Committee Ex Officio Membership
- Dr. Stephen Meyn – Senior Scientist, Genetics & Genome Biology.
- Dr. Elise Heon, Director of the Ocular Genetics Program, Department of Opthamology
- Judy Van Clieaf – Vice President, Clinical Programs
Why a Blueprint for Change?
The Centre for Genetic Medicine Blueprint for Change will be created to assist in the development and execution of a strategy for the centre and create a roadmap that will guide leaders, health professionals, educators, government and patients on how to make individualized medicine a reality at SickKids. The Blueprint is a starting point and identifies leadership, collaboration, education and partnerships as the most critical accelerators for change.
The steps outlined in the Centre Blueprint will:
- Identify the centre’s immediate, medium and long-term priorities to achieve its vision;
- Build the required infrastructure to support enhanced integration across the organization;
- Identify steps to support the expansion of gene discovery efforts;
- Strengthen translation of genetic findings into clinical laboratory tests and patient care;
- Develop knowledge transfer opportunities for health professionals and families;
- Create processes to institutionalize innovation in genetic medicine;
- Strengthen planning to lead national and provincial collaboration, building sustainability and knowledge across the health-care system
- Eriskay Liston, Genetic Counsellor